Follow us on:
Breaking News
September 23, 2026
Breaking News
Breaking News
Adare_CP_Leaderboard_0926
Editor’s Pick
Cryoport_Podcast_0926_FeaturedSpotlight

Lilly Breaks Ground on $6.5B Houston Manufacturing Site

 
Lilly Breaks Ground on $6.5B Houston Manufacturing Site

The new Texas facility will produce Lilly’s oral GLP-1 medicine Foundayo and other small-molecule therapies.
Read More >>

Solvias_Webinar_09-29-26_650x90-POSTPONED-DATE
Headlines

Breaking News

Novo Nordisk to Acquire Three Obesity Drug Programs from Kallyope

Deal adds non-incretin obesity assets, including IND-ready peptide candidate K-554, as Novo seeks to broaden its metabolic pipeline.

SPONSOR

Boost Biosimilar Yields with Efficient-Pro Medium

See how Fresenius Kabi boosted titers, improved glycans, and reduced variants with Gibco Efficient-Pro Medium—ready for scale.

Breaking News

Telix to Buy ITM in $1.65B Radiopharma Deal

The acquisition adds isotope production, manufacturing, and late-stage therapeutic assets to Telix’s radiopharmaceutical platform.

Breaking News
Collaborations & Alliances

Bespak and Upperton Partner on Nasal Drug Delivery

The CDMO collaboration will combine Bespak’s nasal device portfolio with Upperton’s formulation, analytical and clinical manufacturing expertise.

SPONSOR

Real GSK Data: Faster HCP and Protein A Impurity Testing

See case study results on host cell protein and residual Protein A detection using label-free biosensor technology. Download the eBook.

ContractPharma_Conference_2026_650x250

Breaking News

WuXi XDC Secures GMP Release for Singapore Manufacturing Site

The designation applies to the site’s BCM3 antibody intermediate and conjugated drug substance dual-function production line, and DP4 facility.

SPONSOR

Packaging Is Where Timelines Hold—or Slip

Why sponsors are taking a closer look at contract packaging as a driver of speed, control, and execution.

Featured Resources

Solution Center SPOTLIGHT

Aphena Pharma Solutions

Aphena Pharma Solutions is service provider in the pharmaceutical, medical device and biologics industries. Through excellence and innovation, we provide clients with a full range of pharmaceutical packaging and manufacturing services to advance their products to market–complete, on time, on budget. With our continued investment in technology, advanced packaging systems and rigorous cost control, Aphena can deliver solutions that are highly cost effective as well as comprehensive. Through every step in the product launch or transfer process including laboratory support, manufacturing, packaging and distribution, we provide clients with pharmaceutical services to help ensure a successful product launch and year-over-year growth.

 

Solution Center SPOTLIGHT

ESTEVE CDMO

We are a leading provider of high-quality small-molecule APIs and pharmaceutical intermediates. With over 55 years of expertise and a proven track record in developing numerous new chemical entity (NCE) products across diverse therapeutic areas, we have established ourselves as a trusted partner for innovative pharmaceutical companies worldwide.